Department of Pediatrics, Division of Immunology-Rheumatology, Dokuz Eylul University Hospital, Balcova, Izmir, Turkey.
Clin Rheumatol. 2011 Sep;30(9):1189-93. doi: 10.1007/s10067-011-1724-3. Epub 2011 Mar 15.
The objective of this prospective cross-sectional study was to compare a Mycobacterium tuberculosis-specific interferon gamma (IFN-γ) enzyme linked immunosorbent assay [QuantiFERON-TB Gold In-Tube (QFT-GIT)] test with tuberculin skin test (TST) for detection of latent tuberculosis infection (LTBI) in patients with juvenile idiopathic arthritis (JIA). To our knowledge, this is the first study evaluating the performance of QFT-GIT in comparison with TST in JIA. A cross-sectional study of 39 children with JIA and 40 healthy controls was conducted in İzmir, Turkey. Blood was for drawn for the QFT-GIT assay prior to administration of the TST using 5 tubercullin units (TU) of purified protein derivative (PPD-S). A positive TST was defined as ≥10 mm for JIA and ≥15 mm for controls. Statistical analysis was performed using SPSS version 16.0 for Windows. There were no significant differences between JIA patients and controls for age, sex, and Bacillus Calmette-Guérin (BCG) vaccination. Of patients, 70% had active JIA disease. The median TST induration was 5.8 mm (±5.7 mm) for JIA and 10.7 mm (±4.5 mm) for the control group, which was statistically significant (p = 0.000). The rate of patients who showed no reaction to TST was 38%, of which 93% had active disease. There were two patients who had positive IFN-γ results but negative TST, who had systemic and polyarticular type JIA, respectively. Overall agreement between TST and QFT-GIT was low both in JIA and control group (κ value =0.06 and 0.10, respectively). TST may be inadequate to diagnose LTBI in JIA patients. The IFN-γ assay may be useful to identify false negative TST response in cases with latent M. tuberculosis infection. The combination of IF QFT-GIT method with TST would provide successful diagnostic screening for LTBI in JIA, particularly prior to anti-tumor necrosis factor treatment. Long-term prospective studies are still necessary to appreciate the advantages and the applicability of these tests in pediatrics.
本前瞻性横断面研究的目的是比较结核分枝杆菌特异性干扰素γ(IFN-γ)酶联免疫吸附试验[QuantiFERON-TB Gold In-Tube(QFT-GIT)]与结核菌素皮肤试验(TST),以检测幼年特发性关节炎(JIA)患者的潜伏性结核感染(LTBI)。据我们所知,这是第一项评估 QFT-GIT 与 TST 在 JIA 中表现的研究。在土耳其伊兹密尔进行了一项包含 39 例 JIA 患儿和 40 例健康对照者的横断面研究。在给予 5 结核菌素单位(TU)纯化蛋白衍生物(PPD-S)的 TST 之前,抽取血液进行 QFT-GIT 检测。JIA 患者的阳性 TST 定义为≥10mm,对照组为≥15mm。使用 Windows 版 SPSS 16.0 进行统计分析。JIA 患者与对照组在年龄、性别和卡介苗(BCG)接种方面无显著差异。其中 70%的患者存在活动性 JIA 疾病。JIA 组 TST 硬结的中位数为 5.8mm(±5.7mm),对照组为 10.7mm(±4.5mm),差异有统计学意义(p=0.000)。未出现 TST 反应的患者比例为 38%,其中 93%存在活动性疾病。有 2 例患者 IFN-γ 结果阳性但 TST 阴性,分别患有全身型和多关节型 JIA。TST 与 QFT-GIT 在 JIA 患者和对照组中的总体一致性均较低(κ 值分别为 0.06 和 0.10)。TST 可能不足以诊断 JIA 患者的 LTBI。IFN-γ 检测可能有助于确定潜伏性 M. tuberculosis 感染的假阴性 TST 反应。QFT-GIT 方法与 TST 的联合应用将为 JIA 中的 LTBI 提供成功的诊断筛查,尤其是在进行抗肿瘤坏死因子治疗之前。仍需要进行长期的前瞻性研究,以了解这些检测方法在儿科中的优势和适用性。